J2H Biotech
PrivateLast Round
Private Equity
Jul 9, 2021
Est. Valuation
$94.1M
Total Funding Raised
$55.34M
Company Overview
J2H Biotech operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Private Equity round in July 2021.
J2H Biotech is a biopharmaceutical company that develops small molecule therapeutics for rare and incurable diseases and provides CDMO services for pharmaceutical ingredients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
J2H Biotech Comparables
Compare J2H Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Therasid Bioscience | 75% | |
| Nimbus Therapeutics | 69% | |
| Hanmi Pharm Co Ltd | 67% |
For institutional investors. Book with your work email.
J2H Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jul 9, 2021 | ||||
| Series C | Jul 7, 2020 | ||||
| Series B | Jun 18, 2018 | ||||
| Series A | Dec 1, 2016 |
For institutional investors. Book with your work email.
J2H Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KOTEC | Series A |
| Renaissance Asset Management | Series C |
| BNH INVESTMENT | Series A |
| KB Investment | Private Equity |
| Company K Partners | Private Equity |
| LSK Investment | Series A |
| Daol Investment | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 7, 2020
$11M round raised from multiple investors.
- Jun 18, 2018
$10M round led by Ahngook Pharm
For institutional investors. Book with your work email.
J2H Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about J2H Biotech's valuation, stock price, and market status.
Is J2H Biotech a public or private company?
J2H Biotech is a private company.
What is the current stock price of J2H Biotech?
J2H Biotech is a private company, so its shares have no public market price. Caplight tracks J2H Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is J2H Biotech worth (valuation)?
J2H Biotech's valuation is estimated at $94.1M based on funding round data.
Can I buy J2H Biotech stock?
J2H Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was J2H Biotech's last funding round?
J2H Biotech's most recent funding round was Private Equity on July 9, 2021.
Who are the main investors in J2H Biotech?
Key investors in J2H Biotech include KOTEC, Renaissance Asset Management, BNH INVESTMENT, KB Investment, Company K Partners.
Will J2H Biotech IPO soon?
No public IPO plans have been announced for J2H Biotech.
How can I track J2H Biotech secondary market activity?
Caplight tracks bids, offers, and trades in J2H Biotech's shares on secondary markets.